# A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib (PD-0332991) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women of Non-Childbearing Potential.

> **NCT01756781** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Midazolam
- **DRUG:** PD-0332991
- **DRUG:** Midazolam
- **DRUG:** PD-0332991

## Key facts

- **NCT ID:** NCT01756781
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01756781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01756781, "A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib (PD-0332991) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women of Non-Childbearing Potential.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01756781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*